10X Genomics, Inc. (TXG)
71.55
+1.80
(+2.58%)
USD |
NASDAQ |
Oct 23, 16:00
71.60
+0.05
(+0.07%)
After-Hours: 20:00
10X Genomics Market Cap : 9.322B for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 9.322B |
| October 22, 2026 | 9.087B |
| October 21, 2026 | 9.848B |
| October 20, 2026 | 9.310B |
| October 19, 2026 | 9.105B |
| October 16, 2026 | 9.102B |
| October 15, 2026 | 9.431B |
| October 14, 2026 | 9.524B |
| October 13, 2026 | 9.353B |
| October 12, 2026 | 9.796B |
| October 09, 2026 | 10.51B |
| October 08, 2026 | 10.07B |
| October 07, 2026 | 9.914B |
| October 06, 2026 | 10.51B |
| October 05, 2026 | 12.73B |
| October 02, 2026 | 12.18B |
| October 01, 2026 | 11.56B |
| September 30, 2026 | 11.77B |
| September 29, 2026 | 11.73B |
| September 28, 2026 | 11.53B |
| September 25, 2026 | 11.17B |
| September 24, 2026 | 10.96B |
| September 23, 2026 | 9.852B |
| September 22, 2026 | 10.51B |
| September 21, 2026 | 10.31B |
| Date | Value |
|---|---|
| September 18, 2026 | 9.980B |
| September 17, 2026 | 10.03B |
| September 16, 2026 | 9.469B |
| September 15, 2026 | 9.692B |
| September 14, 2026 | 9.134B |
| September 11, 2026 | 8.936B |
| September 10, 2026 | 8.648B |
| September 09, 2026 | 8.767B |
| September 08, 2026 | 8.547B |
| September 04, 2026 | 8.162B |
| September 03, 2026 | 8.236B |
| September 02, 2026 | 8.032B |
| September 01, 2026 | 7.814B |
| August 31, 2026 | 8.136B |
| August 28, 2026 | 8.018B |
| August 27, 2026 | 8.449B |
| August 26, 2026 | 8.372B |
| August 25, 2026 | 8.432B |
| August 24, 2026 | 8.312B |
| August 21, 2026 | 8.484B |
| August 20, 2026 | 8.321B |
| August 19, 2026 | 8.102B |
| August 18, 2026 | 7.248B |
| August 17, 2026 | 7.555B |
| August 14, 2026 | 7.308B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Twist Bioscience Corp. | 8.769B |
| Tempus AI, Inc. | 12.17B |
| Intellia Therapeutics, Inc. | 1.570B |
| Personalis, Inc. | 1.686B |
| Alamar Biosciences, Inc. (California) | 2.130B |
Market Cap Related Metrics
| PS Ratio | 14.81 |
| Price to Book Value | 11.29 |
| Price to Free Cash Flow | 75.25 |
| Price | 71.55 |
| Earnings Yield | -0.82% |